Similar to the increase in PD-1 expression, increasing percentages of T cells in the bone marrow expressed TIM-3, LAG-3 and 2B4 as myeloma burden progressed (Figure 1B). The gene discussed is HAVCR2; the disease is plasma cell myeloma.